Although insomnia due to neurotic illness is one of the commonest of symptoms, reports on the comparative efficacy of hypnotics in man are rare. Werz and Homann (1939) and Cohen and Beecher (1951) made controlled comparative studies but were concerned with the sedative rather than the hypnotic effects of the drugs they used. Meyers, Cook, and Page (1940) In the second place, the conditions necessary for a controlled trial of hypnotics in man are not easily or commonly available, for such a trial requires a series of patients, all suffering from insomnia, under continuous night observation for at least several weeks, and, for preference, sufficiently co-operative and intelligent to give an account of how they slept. These conditions, however, may be fulfilled in hospital wards for the treatment of neurotic patients.
Although insomnia due to neurotic illness is one of the commonest of symptoms, reports on the comparative efficacy of hypnotics in man are rare. Werz and Homann (1939) and Cohen and Beecher (1951) made controlled comparative studies but were concerned with the sedative rather than the hypnotic effects of the drugs they used. Meyers, Cook, and Page (1940) investigated the hypnotic action of five drugs and a placebo in chronically ill patients. but did not attempt to compare the hypnotics with one another. A search through the literature of the past 20 years has not revealed any other relevant work. There are a number of probable reasons why the problem has not been studied more.
In the first place, there is wide individual variation in the response to a hypnotic drug. If it were also true that an individual's response to one hypnotic bore little relation to his response to another, then there would be no value in attempting to compare the efficacy of different hypnotics in a series of patients. Yet this point is one that does not seem to have been established, and on theoretical grounds we might expect that the comparative efficacy of different hypnotics would remain the same in different individuals provided the cause of the insomnia was the same.
In the second place, the conditions necessary for a controlled trial of hypnotics in man are not easily or commonly available, for such a trial requires a series of patients, all suffering from insomnia, under continuous night observation for at least several weeks, and, for preference, sufficiently co-operative and intelligent to give an account of how they slept. These conditions, however, may be fulfilled in hospital wards for the treatment of neurotic patients.
In the third place, so many efficacious hypnotics are available that to compare them might seem a work of supererogation. Indeed, in prescribing hypnotics the practitioner suffers an embarras de richesse, and in consequence either tends to confine himself to the use of one or two "favourite" hypnotics or administers a succession of newly-marketed drugs, the comparative efficacy of which has rarely been the subject of a controlled trial.
A satisfactory means of comparing the clinical efficacy of hypnotics would have two valuable uses. It would enable new hypnotics to be tested against long-established drugs, and it would permit a comparison of the efficacy of those already in common use. The common hypnotics are usually prescribed in a dosage which experience has shown as that which gives most patients reasonable relief from insomnia and at the same time is associated with a minimum of undesirable side-effects; it has not, however, been clearly established whether there is any significant difference in the efficacy of these drugs when given in their commonly prescribed dosage. If such differences could be established, then, other things being equal, it would be rational to administer the hypnotic which a controlled trial showed to be most effective.
PRESENT INVESTIGATIONS Hogben and Sim (1953) have outlined a method for determining the effect of treatment in low-grade morbidity by means of a self-controlled and selfrecorded clinical trial. The present investigation was planned as an attempt to study, by this method, the comparative efficacy of hypnotics in patients suffering from neurotic insomnia.
In a self-recorded trial it is necessary to detnonstrate the reliability of the self-record by checking it against an independent objective assessment. Two main checks were used in the present investigation, where the self-record was the patient's opinion of the quality of his night's sleep: the first, an external check, was the night-nurse's record of the patient's sleep; the second, an internal check, was achieved by giving the patient the same hypnotic drugs in differently coloured capsules. If (i) Trial A (six subjects).-The effect of butobarbitone gr. 3 was compared with that of carbromal gr. 12 and also with that of a lactose placebo. The capsules containing these drugs were all identical in appearance, but half of the capsules were coloured red and half were coloured blue. They were administered in a pre-arranged random order (known only to the dispenser), such that over a period of eighteen nights a patient would receive each drug six times, three times in a red capsule and three times in a blue. The patients were not told they were receiving different types of drug; to minimize the chance of their noticing a difference in taste, the capsules were taken under the supervision of the night-nurse and the patients were asked to swallow them whole with a drink of water. To ensure that each patient had the correct capsules, these were sent from the dispensary in separate envelopes on which was written the name of the patient and the date on which the dose was to be taken.
(ii) Trial B (five subjects).-Sodium butobarbitone gr. 3 was compared with methylpentenol 0 3 g. and with a placebo. As methylpentenol is a liquid, it is administered in special soft elastic gelatine capsules. It was therefore necessary to administer the other drugs in a similar manner; to this end, arachis oil was used as a placebo, and the sodium butobarbitone was dissolved in propylene glycol (butobarbitone is insufficiently soluble for this purpose and therefore could not be used).
(iii) Trial C (thirteen subjects).-Sodium butobarbitone gr. 3 was compared with methylpentenol 0 5 g. No placebo control was used.
(iv) Trial D (six subjects).-Sodium butobarbitone gr. 3 was compared with carbromal gr. 12, without a placebo control. The drugs were administered in differently coloured capsules as in Trial A. As 3 gr. sodium butobarbitone is equivalent in barbiturate content to 2-72 gr. butobarbitone, we should expect to find that the efficacy of the barbiturate as compared with carbromal would be less in Trial D than in Trial A.
RECORD CHARTS
In general, a person will consider she has had a good night's sleep if she:
(i) got off to sleep quickly, (ii) slept soundly for about 8 hours, (iii) had no periods of wakefulness, (iv) had no disturbing dreams, (v) felt fresh on waking.
Any scheme that takes account of these factors should give an adequate record. . (4) bad .
. (6) very quickly. From the nurse's point of view, a patient slept well if she:
(i) was observed to be asleep for the greater part of the night, (ii) was not restless.
The night-nurse kept a record which was scored as follows:
one mark for each half-hour awake between the hour of 10 p.m. and 7 a.m.; one mark if there were one or two periods of night waking, two marks if more than two such periods; one mark if a patient was recorded as "somewhat restless", two marks if "very restless".
If there was "considerable" (as opposed to "none" or "slight") disturbance in the patient's ward, one mark was subtracted. A satisfactory night's sleep would thus score no marks, a sleepless and restless night could score 20 marks.
If the records are reliable, then with one factor excepted the score from the nurse's record should show a high correlation with that from the patient's record. The excepted factor is the patient's estimate of how she felt on waking (it may be called the "hangover" score) as this has no counterpart in the nurse's record. Therefore, for the purpose of correlating the nurse's record against the patient's, the hangover score must be omitted.
OTHER CONSIDERATIONS
All the patients continued, during their period of trial, to have whatever methods of treatment seemed appropriate to their illness. In the course of treatment, most of the patients improved and many ceased to need hypnotics. It might be argued that the effects ofa hypnotic cannot be properly evaluated while a patient is undergoing some relatively drastic form of treatment such as electroplexy (sixteen of the thirty patients had this during their hypnotics trial).
However, as no patient goes without some form of treatment, and as the type of hypnotic waschanged every night or every second night, it seemed justifiable to assume that the effects of the treatment on the insomnia would on the whole be evenly spread and would not seriously influence the comparative quality of the sleep obtained with the different drugs. This question is referred to again in the discussion. 1 20 1 00 1 00 2*50 3 07 0 33 0 19 2 14 2-25 2-00 5-83 6-02 2-50 3 00 3 25 1-00 1 95 4-92 5 70 1-00 1*27 D 4 21 2-25 2-17 9 34 9-58 1-00 1-00 5 27 2-60 3*04 6-43 7*07 2-50 2-33 6 17 2-00 1-70 3-63 3 03 1*00 1*25
RESULTS
Total 124 11-10 11*86 32 65 34-77 8 33 9-04 individual variation in the response to a given hypnotic, the comparative activity of two hypnotics was practically the same in the different subjects.
DISCUSSION
Two main criticisms may be made of this investigation: that the number of subjects in each trial is small and that over half the subjects were receiving electroplexy during their period of trial. The numbers are admittedly small; but even in a neurosis ward suitable subjects are not very easily found, for in addition to the requirements mentioned above the patient must be prepared to have a few nights of poor sleep (when receiving the placebo) and his sleep must not be consistently excellent on the drugs tested or there would be no difference to record. However, even with the small number of subjects, the results are sufficiently consistent to make the investigation seem worth reporting. The second criticism is more serious, as electroplexy may disturb a patient's judgment. In Trial A, however, only one of the six subjects (Subject 3) received electroplexy, yet all the trials show a similar degree of consistency. On the other hand, the fact that ten of the thirteen subjects in Trial C and four of the six in Trial D received electroplexy might possibly explain the rather lower correlation between the scores of the patients and of the nurses in these two trials.
If these criticisms are met, then the results of the trial allow of four main conclusions:
(1) Reasons for believing the method to be reliable may be summarized as follows: (i) the patients' self-record of the quality of their (3) In the doses given, the hypnotic drugs administered caused no appreciable subjective feeling of "hangover". Goodnow and others (1951) and Felsinger, Lasagna, and Beecher (1953) have nevertheless shown that there may be impairment of physiological performance after barbiturate in the absence of subjective sensations. The patients' estimates of how they felt on waking was in some respects the least satisfactory part of the trial. One or two of the patients with long-standing neurotic disability seemed to feel they owed it to themselves always to complain of waking up "drugged" whenever they believed they had been given a hypnotic. This is an attitude of mind which might explain the statement of Goodman and Gilman (1955) that "hangover from relatively small hypnotic doses (of barbiturates) occurs especially among neurotic patients".
(4) The results suggest that carbromal in a dose of 12 gr. is less efficacious than butobarbitone gr. 3 but has approximately the same efficacy as sodium butobarbitone gr. 3. Carbromal in a dose of 10-15 gr. would thus appear to be a hypnotic of considerable potency and has perhaps been unduly neglected; the National Formulary (1955), for example, states that it is "a weak hypnotic", while Goodman and Gilman (1955) dismiss the monoureides as "somewhat disappointing due to their feeble depressant effects".
Methylpentenol, on the other hand, in a dose of 0 3 g. proved little better than a placebo, and 0 5 g. was sitll considerably less effective than 3 gr. sodium butobarbitone. Hirsh and Orsinger (1952) , who administered methylpentenol to 276 patients in doses up to 0 5 g., concluded that it was most effective in "simple insomnia" and less so in agitated states; a similar conclusion was reached by Chevalley and others (1952) , and the present trial tends to support these findings.
SUMMARY
(1) This paper describes a self-controlled and selfrecorded clinical trial of the comparative efficacy of three common hypnotic -drugs in thirty patients suffering from neurotic insomnia.
(2) The reliability of the self-records was checked by several independent methods.
(3) This type of trial appears to yield reliable results and could be used to test the efficacy of new hypnotics.
(4) Butobarbitone gr. 3 was shown to give more relief from insomnia than carbromal gr. 12, which in turn was more efficacious than methylpentenol 0-5 g. ADDENDUM After this paper had been written, the author's attention was drawn to the work of Straus, Eisenberg, and Gennis (1955) . By a self-controlled and self-recorded trial, they have compared the hypnotic activity of an antihistamine with that of phenobarbitone and a placebo. Their method of recording the quality of sleep was somewhat different, and their statistical analysis was more complex than that used in the present investigation; but the underlying principle and general conclusions as to the suitability of the method for comparing the action of hypnotics were the same.
